Bild
We have a strong and competitive pharmaceutical pipeline here! It's with pride and joy that I read the report "The Swedish Drug Discovery and Development Pipeline 2023", released by SwedenBIO earlier in March. But of the 74 companies that filled in the survey, 68 percent conduct their clinical trials outside Sweden. Only 19 percent of the companies do their tests primarily in Sweden, and 14 percent do both abroad and at home.
